There are 71 resources available
An Asian patient clinical case focusing on ‘Before’ and ‘After’ the implementation of the practice-changing studies in the local/national context
Presenter: Evelyn Wong
Session: Current standards and practice changing studies in lower gastrointestinal cancers
Resources:
Slides
Webcast
Discussion
Presenter: Andres Cervantes
Session: Current standards and practice changing studies in lower gastrointestinal cancers
Resources:
Webcast
Practice changing studies in localized/early disease
Presenter: Ravindran Kanesvaran
Session: Current standards and practice changing studies in genitourinary cancers
Resources:
Slides
Webcast
Practice changing studies in locally advanced/metastatic disease
Presenter: Thomas Powles
Session: Current standards and practice changing studies in genitourinary cancers
Resources:
Slides
Webcast
An Asian patient clinical case focusing on ‘Before’ and ‘After’ the implementation of the practice-changing studies in the local/national context
Presenter: Yuji Miura
Session: Current standards and practice changing studies in genitourinary cancers
Resources:
Slides
Webcast
Discussion
Presenter: Thomas Powles
Session: Current standards and practice changing studies in genitourinary cancers
Resources:
Webcast
Optimizing management of ER+ HER2- mBC through Clinical & Real World Evidence
Presenter: Reshma Mahtani
Session: Pfizer Corporation Hong Kong Limited - Transforming care in ER+ HER2- metastatic breast cancer with a focus on CDK4/6 inhibition
Resources:
Webcast
The Era of the Empowered mBC Patient
Presenter: Liz O’Riordan
Session: Pfizer Corporation Hong Kong Limited - Transforming care in ER+ HER2- metastatic breast cancer with a focus on CDK4/6 inhibition
Resources:
Webcast
Experience sharing: clinical case presentation 1
Presenter: Chirag Desai
Session: Pfizer Corporation Hong Kong Limited - Transforming care in ER+ HER2- metastatic breast cancer with a focus on CDK4/6 inhibition
Resources:
Webcast
Experience sharing: clinical case presentation 2
Presenter: Tira Tan
Session: Pfizer Corporation Hong Kong Limited - Transforming care in ER+ HER2- metastatic breast cancer with a focus on CDK4/6 inhibition
Resources:
Webcast